Why Do a Significant Number of GLP-1 Users Stop Taking the Medication in the First Year
Neither is clearly better for people with diabetes and both medicines are approved for type 2 diabetes at certain doses and have strong evidence for lowering A1C and improving blood sugar
[19] The classical effect of prolonged use both in adult and paediatric population is steatosis
The long-acting strategies of GLP-1 drugs (amino acid substitutions, fatty acid side chain modifications, Fc fusion proteins, PEGylation) described in the article are only a small part of the current long-acting strategies, which have actually been applied to other protein-peptide drugs as early as
In fact, studies noted around a 4% weight reduction in the first month on average [33][34]
[10] In the 12-week study on middle-aged women cited above, the researchers found that HMB has an incredible ability to reduce intramuscular adipose tissue (IMAT), a type of fat infiltration within muscle tissue that can compromise metabolic health